SCR-LIP-000648 · Claim · machine-readable JSON →
Rare variants in hormone-metabolism genes such as AKR1C1 have been reported in isolated lipedema families, but replication is lacking.
General proposition consolidated from 6 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 6 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (6)
- Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema — Michelini et al. (2020) ✓ verified — consistent · case report · 2020 · reading confidence: high
“Variante AKR1C1 c.638T>A; p.L213Q identificada exclusivamente nas 3 pacientes afetadas e ausente nos 9 membros não afetados da família Sanger sequencing confirmou segregação perfeita com o fenótipo lipedema”
Exome sequencing in an autosomal dominant family: AKR1C1 p.L213Q present in all 3 affected (puberty onset) and absent in 9 unaffected members; predicted partial loss of progesterone catabolism.
The article reports a hereditary (autosomal dominant) gene variant segregating with lipedema and links a hormonal mechanism (progesterone metabolism via 20α-HSD) to disease onset at puberty, directly supporting both heredity and hormonal in - From rare familial mutations to multifactorial disease: aldo-keto reductase 1C enzymes as a central biological pathway in lipedema — Vainberg et al. (2026) ✓ verified — contextual · review · 2026 · reading confidence: high
“Variante AKR1C1 p.Leu213Gln (L213Q) — descrita por Michelini et al. — segrega com lipedema em 3 gerações”
Review re-reporting AKR1C1 L213Q segregating across three generations and proposing AKR1C enzymes, AKR1C2 variants and regulatory polymorphisms as a steroid-metabolism pathway in gluteofemoral fat.
Review articulating a gene-environment model in which both heredity (familial AKR1C mutations and regulatory polymorphisms) and hormones (steroid metabolism, endocrine disruptors) influence lipedema onset, directly supporting the question's - Lipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) ✓ verified — contextual · review · 2025 · reading confidence: high
“mutação em AKR1C1 (aldo-ceto redutase que catalisa redução de progesterona em 20α-hidroxiprogesterona) em caso familiar; mutação em PIT1 (fator de transcrição para GH, prolactina, TSH-β) em caso esporádico — ambos corroboram influência hormonal na etiologia”
Review re-reporting the familial AKR1C1 mutation (progesterone reduction), adding a PIT1 mutation (GH, prolactin, TSH-beta) in one sporadic case; 18 GWAS loci; 305 candidate genes sequenced.
The review synthesizes genetic studies (GWAS, sequencing) showing heritable loci and monogenic mutations in hormone-related genes (AKR1C1 affecting progesterone, PIT1 affecting GH/prolactin/TSH), directly supporting both hereditary and horm [grade capped moderate->very_low per curated Oxford N6] - AKR1C1 and hormone metabolism in lipedema pathogenesis: a computational biology approach — Kaftalli J et al. (2023) ✓ verified — consistent · basic science · 2023 · reading confidence: high
“Três variantes missense em AKR1C1 identificadas em pacientes com lipedema: Leu54Val (L54V), Leu54Phe (L54F) e Asn280Lys (N280K) — todas disruptivas à função enzimática”
Targeted sequencing found three missense AKR1C1 variants (L54V, L54F, N280K) in lipedema patients; molecular dynamics predicted disrupted substrate or cofactor binding; 8 rare gnomAD variants flagged as potentially pathogenic.
The article directly identifies specific AKR1C1 genetic variants in lipedema patients and characterizes their predicted pathogenicity via computational/structural biology, directly addressing the question on genetic variants. Confidence is - Lipedema Research—Quo Vadis? — Ernst et al. (2023) ✓ verified — contextual · review · 2023 · reading confidence: high
“Variante missense no gene AKR1C1 (aldo-ceto redutase envolvida no metabolismo da progesterona) — primeiro gene mutado identificado em família com lipedema primário não sindrômico”
Review cites the AKR1C1 missense variant as the first mutated gene identified in a family with non-syndromic lipedema.
The review explicitly describes inheritance patterns (X-linked dominant/autosomal dominant with incomplete penetrance, oligogenic) and names a specific variant (AKR1C1 missense) identified in primary lipedema, directly addressing the questi [grade capped moderate->very_low per curated Oxford N6] - Impact of hormones on lipedema development: a systematic literature review — Lüchinger et al. (2026) ✓ verified — contextual · review · 2026 · reading confidence: moderate
“AKR1C1 missense variant (Michelini 2020): clearance de progesterona reduzido, aumento adipogênese via ADD1/SREBP1c, redução PGF2”
Systematic review cites the AKR1C1 variant with reduced progesterone clearance and increased adipogenesis, plus a familial Pit1 mutation with GH and testosterone deficiency.
The review explicitly cites a familial genetic study and a specific AKR1C1 missense variant plus other gene-level findings (ZNF423, CAV1), directly bearing on genetic variants in lipedema, though genetics is a secondary focus of this hormon
Context (PECO)
Answers these questions
- Do hormones and heredity influence the onset of lipedema? consistent
- What specific genetic variants or inheritance patterns have been identified in lipedema? consistent
- Is lipedema onset influenced by heredity and family history? consistent
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000012